CiteReady is an online personal knowledge management tool. Click to find out more!
5 of 202 articles - Show All
  1. Feldman, Holtzman, Jagust, Petersen, Snyder, and Phelps.

    The Diagnosis of Mild Cognitive Impairment Due to Alzheimers Disease Recommendations from the National Institute on AgingAlzheimers Association Workgroups on Diagnostic Guidelines for Alzheimers Disease Alzheimers Dementia 7 , Volume 3 , Issue 2011 Pages: 270-79
    A B , Howard H , Marilyn S , Steven T , Nick C , David M , William J , Ronald C , D D , Peter J , Maria C , Creighton H , F A , C B
  2. Inflammation and Alzheimer's disease.

    Neurobiology of aging , Volume 21 , Issue 3 (2000)
    Akiyama H , Barger S , Barnum S , Bradt B , Bauer J , Cole G M , Cooper N R , Eikelenboom P , Emmerling M , Fiebich B L , Finch C E , Frautschy S , Griffin W S , Hampel H , Hull M , Landreth G , Lue L , Mrak R , Mackenzie I R , McGeer P L , O'Banion M K , Pachter J , Pasinetti G , Plata-Salaman C , Rogers J , Rydel R , Shen Y , Streit W , Strohmeyer R , Tooyoma I , Van Muiswinkel F L , Veerhuis R , Walker D , Webster S , Wegrzyniak B , Wenk G , Wyss-Coray T
  3. Akaike, Akinori. "Preclinical Evidence of Neuroprotection by Cholinesterase Inhibitors.

    Alzheimer Disease Associated Disorders 20Supplement , Volume 1 , Issue 2006
  4. Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models:

    Nature Communications , Volume 7 (2016)
    Daniels M , Jack R , Tom S , Spencer N , William W
  5. Inflammasomes as therapeutic targets for Alzheimer's disease

    Brain Pathology , Volume 27 , Issue 2 (2017)
    White C , Lawrence C , Brough D , Rivers-Auty J
(No collections found)